Study guide
4.3 Refills & Authority Limitations
Pennsylvania MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the PA MPJE Exam 1.2 How to Use This Study Guide
2 Federal Pharmacy Law Foundations
2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Forms, Registration & Security 2.3 Federal Food, Drug, and Cosmetic Act 2.4 HIPAA & Patient Privacy 2.5 OBRA '90, Medicare/Medicaid & DUR 2.6 DSCSA & Drug Supply Chain Integrity
3 Area 1: Licensure & Personnel (22%)
3.1 Pharmacist Licensure & the PA Board of Pharmacy 3.2 Pharmacist-in-Charge Responsibilities 3.3 Pharmacy Interns & Practical Experience 3.4 Pharmacy Technicians & Trainees (PA Registration) 3.5 License Renewal, CE & Discipline 3.6 Impaired-Pharmacist Programs & Mandatory Reporting
4 Area 2: Pharmacist Practice (33%)
4.1 Prescription Requirements & Practitioner Authority 4.2 Controlled Substance Prescribing (Federal + PA) 4.3 Refills & Authority Limitations 4.4 Drug Administration & Collaborative Practice Agreements 4.5 Patient Counseling & Documentation 4.6 Returning & Reusing Drugs 4.7 Immunizations, Naloxone & Public Health 4.8 Patient Confidentiality & Pharmacy Records
5 Area 3: Dispensing Requirements (24%)
5.1 Legitimate Medical Purpose Verification 5.2 Prescription Transfers Between Pharmacies 5.3 Prospective DUR & the PA PDMP (ABC-MAP) 5.4 Refill Exceptions & Emergency Dispensing 5.5 Labeling of Dispensed Drugs 5.6 Packaging of Dispensed Drugs 5.7 Drugs & Conditions Prohibiting Dispensing 5.8 OTC, Behind-the-Counter & Hazardous Drugs
6 Area 4: Pharmacy Operations (21%)
6.1 Ordering, Acquisition & Distribution Records 6.2 Recordkeeping, Storage & Handling 6.3 Controlled Substance Inventories 6.4 Delivery of Drugs 6.5 Product Selection & Generic Substitution 6.6 Compounding: Sterile, Nonsterile & Hazardous 6.7 Central Fill & Centralized Prescription Processing 6.8 Pharmacy Permits, Inspections & Discipline
7 Test-Day Strategy & Final Review
7.1 When PA Law Is Stricter Than Federal Law 7.2 Test-Day Strategy & Common Traps
4.3 Refills & Authority Limitations
Key Takeaways Explain This Topic AI
Schedule II prescriptions have no refills; the only federal exception is a compound for direct administration to a patient in a long-term care facility or terminally ill patient.
Schedule III and IV prescriptions may be refilled up to 5 times within 6 months of the original issue date if authorized by the prescriber; no refill may be dispensed after 6 months even if refills remain. Federally, Schedule V refills are as the prescriber authorizes.
Non-controlled prescriptions in PA may be refilled only as authorized by the prescriber and within 1 year of the original issue date, consistent with federal FDCA and PA labeling rules.
A paper or oral CII prescription may not be transferred, and federally an unfilled electronic CII prescription may be transferred once for initial filling at the patient's request (21 CFR 1306.08(e)); CIII–CV transfers are allowed with full documentation; non-controlled transfers are permitted for refill purposes.
Changing "dispense as written" status or refill count requires a new prescription or a documented prescriber authorization; pharmacists may not unilaterally extend refills.
Last updated: November 2026
Refill Authority by Schedule
Refill authority is a function of the drug's federal schedule and the prescriber's authorization. PA does not expand federal refill authority; when PA is silent, federal law controls.
- Schedule Federal Refill Limit PA Rule Time Bar
- CII No refills (21 CFR § 1306.12) Same — no refills (35 P.S. § 780-112) n/a
CII — LTC/terminally ill Refills of compound for direct administration permitted (21 CFR § 1306.12(a)) Same Per Rx
CIII–CIV Up to 5 refills within 6 months of issue (21 CFR § 1306.22) Same 6 months from issue, even if refills remain
CV As authorized by the prescriber (21 CFR § 1306.22 covers CIII–CIV only) — No federal time bar
Non-controlled legend 1 year from issue (FDCA / PA labeling § 27.18) 1 year from issue, unless prescriber specifies shorter 1 year from issue
- OTC None required; sold as needed Pharmacy may not require an Rx for OTC n/a
- CII — No Refills, Narrow Exception
A CII prescription may not be refilled. A patient who needs more of the drug must obtain a new prescription . The only federal exception is for a compound prescribed for direct administration to a patient in a long-term care facility or to a terminally ill patient, where the prescription may be refilled under the practitioner's authorization.
A pharmacist who refills a routine CII prescription for an outpatient is violating both federal and PA law, regardless of prescriber instruction. "The prescriber said to refill it" is not a defense — the pharmacist shares corresponding responsibility.
CIII–CIV — Five Refills in Six Months
A CIII or CIV prescription may be refilled (federally, a CV prescription is refilled as the prescriber authorizes):
Up to 5 times if authorized by the prescriber (21 CFR § 1306.22), and
Only within 6 months of the date of issue.
If a prescription is written for "5 refills" but is issued on January 1, the patient may not refill on July 15 even though one refill remains — the 6-month window has expired. After expiration, a new prescription is required.
A pharmacist must record each refill on the back of the prescription (or in the pharmacy's electronic record), noting the date, quantity, and pharmacist initials, and must update the patient profile.
Non-Controlled Legend Drugs — PA Rule
For non-controlled legend (prescription) drugs, the prescriber must authorize refills on the prescription. PA follows the federal standard: refills may be dispensed within 1 year of the original issue date , but no longer. A prescriber may specify a shorter refill count or expiration (e.g., "refill PRN x 3, expires in 90 days").
If the prescriber writes "refill PRN" or "refill x 12" without an expiration, the pharmacist may dispense refills up to 1 year from the original issue date. Beyond 1 year, a new prescription is required even if refills remain.
Refill Transfers Between Pharmacies
Federal and PA transfer rules differ by schedule:
CII : No refill transfers, and a paper or oral CII cannot be transferred. Federally, an unfilled electronic CII prescription may be transferred once for initial filling at the patient's request, where Pennsylvania law allows (21 CFR 1306.08(e), (g)).
CIII–CV : Transfers are permitted with full documentation of the original Rx, refill history, and dates; the transfer must be communicated directly between pharmacists, and the transferring pharmacy must void the original.
Non-controlled : Transfers are permitted for refill purposes. The receiving pharmacy records the original Rx number, prescriber, drug, and remaining refills; the transferring pharmacy removes the prescription from its active file or marks it as transferred.
Transfers for the purpose of dispensing a controlled substance by means other than a direct pharmacist-to-pharmacist communication (e.g., a patient carrying a bottle to another pharmacy and the new pharmacy refilling) are not valid transfers and amount to unauthorized refills.
Quantity Limits and "Dispense as Written"
A prescriber may specify a quantity limit (e.g., "dispense 30, no refills"). PA generic substitution law permits the pharmacist to substitute a therapeutically equivalent generic (AB-rated) unless the prescriber writes "dispense as written" (DAW) or "brand medically necessary." When substitution is permitted and used, the pharmacist must pass the lower acquisition cost to the patient and payer.
Changing Refill Authorization or DAW Status
A pharmacist may not unilaterally:
- Add or remove refills,
- Change the quantity,
- Change the dispense-as-written/DAW designation, or
Change the drug or strength.
Any of these changes requires a new prescription or a documented prescriber authorization (oral authorization reduced to writing, with the prescriber's name, date, and pharmacist initials). For controlled substances, the change must be initialed and dated by the pharmacist on the original prescription or in the electronic record.
MPJE Refill Traps
A CII prescription written for "30 tabs, 5 refills" may be filled only once; the 5 refills are void. The pharmacist should dispense the original quantity and inform the patient that a new prescription is needed for further supply.
A CIII prescription dated December 1 with 5 refills may be refilled only through May 31 of the following year (6-month window), regardless of remaining refills.
A CIII transfer to a new pharmacy does not restart the 6-month clock or the 5-refill count — both follow the original prescription.
A patient may not "borrow" refills from another patient's prescription, even for the same drug; prescriptions are patient-specific.